Michael Kody, MD
Orthopaedic Surgery · Spokane, WANPI 1407825599
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (54.4%), food and beverage and charitable contributions — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Arthrex at 53.4% of the total. Reporting peaked in 2019 at $1,538 and has fallen 79.1% since, to $322 in 2025. That places this record below the midpoint for orthopaedic surgery clinicians in WA, where the typical reported total is $2,959.
Across 14 payments — averaging $155.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$1K
- Smith+Nephew$254
- Tracpatch Health, Inc$250
- Sawtooth Surgical Solutions Inc$239
- Stryker$151
- Vericel Corporation$74
- plus $49 from 1 others
What the payments were for
- Food & beverage$74534%
- Education$1,18754%
- Charitable contribution$25011%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 1 | $1,166 |
| Smith+Nephew | 4 | $254 |
| Tracpatch Health, Inc | 1 | $250 |
| Sawtooth Surgical Solutions Inc | 3 | $239 |
| Stryker | 2 | $151 |
| Vericel Corporation | 2 | $74 |
| Pacira Pharmaceuticals Incorporated | 1 | $49 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CONSENSUS HIP SYSTEM$250
- CONSENSUS KNEE SYSTEM$250
- Q-FIX$140
- MAKO$122
How this compares
$2,183 in reported general payments places this provider in the 45th percentile of 495 orthopaedic surgery providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 54 | $1,619 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 87 | $1,062 |
| Oxycodone Hcl | 54 | $324 |
| Amoxicillin | 160 | $322 |
| Cephalexin | 80 | $214 |
| Ondansetron Hcl | 62 | $149 |
| Hydroxyzine Pamoate | 33 | $110 |
| Pregabalin | 16 | $51 |
| Clindamycin Hcl | 12 | $46 |
| Tamsulosin Hcl | 31 | $34 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Spokane
- Tim LovellSpokane$1.8M
- Brett MulawkaSpokane$32K
- William BarrettRenton$7.7M
- James PritchettSeattle$6.4M
- James CrutcherSeattle$3.5M
- Keith MayoSeattle$3.1M
- Matthew SaltzmanSeattle$1.8M
- Timothy AltonRenton$1.5M
- Burt YaszaySeattle$1.3M
- Sean ToomeySeattle$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.